We are live on ! Find out more
MCM

Moore Capital Management Portfolio holdings

AUM $4.92B
1-Year Est. Return 35.41%
This Fund
S&P 500
This Quarter Est. Return
+8.8%
1 Year Est. Return
+35.41%
3 Year Est. Return
+169.06%
5 Year Est. Return
+282.2%
10 Year Est. Return
+2,041.62%
AUM
$4.21B
AUM Growth
-$47M
Cap. Flow
-$196M
Cap. Flow %
-4.66%
Top 10 Hldgs %
39.32%
Holding
820
New
134
Increased
52
Reduced
63
Closed
277

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$258M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$198M
3
FXI icon
iShares China Large-Cap ETF
FXI
+$128M
4
SEDG icon
SolarEdge
SEDG
+$63M
5
TECK icon
Teck Resources
TECK
+$57.2M

Top Sells

Rank Stock Value
1
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$131M
2
CRWD icon
CrowdStrike
CRWD
+$91.1M
3
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$88.1M
4
XOP icon
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
+$64.4M
5
UNM icon
Unum
UNM
+$64.3M

Sector Composition

Rank Sector Weight
1 Financials 18.69%
2 Technology 11.06%
3 Industrials 6.15%
4 Consumer Discretionary 5.6%
5 Healthcare 3.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPWR icon
326
SunPower Inc
SPWR
$61.7M
$1.01M 0.02%
100,000
– –
FTEV
327
DELISTED
FinTech Evolution Acquisition Group
FTEV
$1.01M 0.02%
100,000
– –
AEON icon
328
AEON Biopharma
AEON
$13.2M
$1.01M 0.02%
1,389
– –
JUGG
329
DELISTED
Jaws Juggernaut Acquisition Corporation Class A Ordinary Share
JUGG
$1M 0.02%
100,000
– –
ARYE
330
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$999K 0.02%
100,000
– –
LNZA icon
331
LanzaTech
LNZA
$67.4M
$998K 0.02%
1,000
– –
IRAA
332
DELISTED
Iris Acquisition Corp Class A Common Stock
IRAA
$998K 0.02%
100,000
-400,000
-80% -$3.99M
MEKA
333
DELISTED
MELI Kaszek Pioneer Corp Class A Ordinary Shares
MEKA
$997K 0.02%
100,000
– –
VKTX icon
334
Viking Therapeutics
VKTX
$3.84B
$940K 0.02%
+100,000
New +$446K
STVN icon
335
Stevanato
STVN
$5.33B
$899K 0.02%
50,000
– –
KZR
336
DELISTED
Kezar Life Sciences
KZR
$880K 0.02%
12,500
-5,496
-31% -$408K
AMD icon
337
Advanced Micro Devices
AMD
$840B
$810K 0.02%
+12,500
New +$825K
BCRX icon
338
BioCryst Pharmaceuticals
BCRX
$2.25B
$746K 0.02%
+65,000
New +$811K
HLMN icon
339
Hillman Solutions
HLMN
$1.8B
$721K 0.02%
100,000
+50,000
+100% +$376K
ZGN.WS
340
DELISTED
Ermenegildo Zegna N.V. Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share
ZGN.WS
$700K 0.02%
333,333
– –
AGI icon
341
Alamos Gold
AGI
$12B
$657K 0.02%
65,000
– –
RNW icon
342
ReNew
RNW
$2.28B
$594K 0.01%
+107,922
New +$630K
OMC icon
343
Omnicom Group
OMC
$21.8B
$565K 0.01%
+6,929
New +$514K
CYH icon
344
Community Health Systems
CYH
$408M
$540K 0.01%
125,000
-184,760
-60% -$569K
APLS
345
DELISTED
Apellis Pharmaceuticals
APLS
$517K 0.01%
10,000
-169,958
-94% -$9.01M
NUVA
346
DELISTED
NuVasive, Inc.
NUVA
$516K 0.01%
12,500
– –
AEAE
347
DELISTED
AltEnergy Acquisition Corp
AEAE
$512K 0.01%
50,000
– –
SLAC
348
DELISTED
Social Leverage Acquisition Corp I Class A Common Stock
SLAC
$500K 0.01%
50,000
-150,000
-75% -$1.49M
LCA
349
DELISTED
Landcadia Holdings IV, Inc. Class A Common Stock
LCA
$500K 0.01%
50,000
-350,000
-88% -$3.48M
LEGN icon
350
Legend Biotech
LEGN
$3.69B
$499K 0.01%
+10,000
New +$484K
12 13
14
15 16

Similar funds

SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return
FC
Freemont Capital Singapore $4.91B AUM 5.45% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
CFC
Cincinnati Financial Corp Fairfield, Ohio $4.96B AUM 18.21% 1-Year Est. Return

Moore Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Moore Capital Management held 820 positions worth $4.21B, down 1.1% from $4.26B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Moore Capital Management withdrew a net $196M in Q4 2022, closing 277 positions and reducing 63 holdings. Its most notable exit was CrowdStrike, an estimated $91.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

Against the trend, Moore Capital Management opened a new position in State Street SPDR S&P Biotech ETF worth $264M.

  • Moore Capital Management's largest Q4 2022 buy was State Street SPDR S&P Biotech ETF: 3,182,662 shares worth $264M.
  • Moore Capital Management added most to SolarEdge in Q4 2022, an estimated $63M increase.
  • Moore Capital Management's biggest Q4 2022 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $131M.
  • Moore Capital Management fully exited CrowdStrike in Q4 2022, selling an estimated $91.1M.
  • Moore Capital Management's ten largest holdings make up 39% of its $4.21B portfolio in Q4 2022.
  • Moore Capital Management opened 134 new positions and closed 277 in Q4 2022.
  • Moore Capital Management's portfolio value fell 1.1% quarter-over-quarter to $4.21B.

Based on Moore Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.